Search for Clinical Trial Results

Sponsored By

Renal Medullary Carcinoma - 4 Studies Found

Status Study
Recruiting Study Name: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Condition:
  • Malignant Rhabdoid Tumors (MRT)
  • Rhabdoid Tumors of the Kidney (RTK)
  • Adult Acute Myeloid Leukemia in Remission
  • Childhood Acute Lymphoblastic Leukemia in Remissio
    Date: 2001-12-07
    Interventions:
    • Drug: Fludarabine Phosphate Gi
Recruiting Study Name: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Condition:
  • Carcinoma of the Collecting Ducts of Bellini
  • Chromophobe Renal Cell Carcinoma
  • Date: 2013-01-10
    Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names:
Completed Study Name: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
Condition:
  • Renal Cell Cancer
  • Kidney Cancer

Date: 2007-04-20
Interventions: Drug: Sunitinib Malate 50 mg by mouth daily for 4 weeks, then 2 weeks off.